Researchers watch in real time as fat-encased drug nanoparticles invade skin cells

CU Cancer Center study describes use of cutting-edge microscopy technology to visualize how liposomes escape from blood vessels into surrounding cells in a living mouse, offering clues that may help researchers design better drug delivery systems

Read the rest of this entry

Clinical Trials 101

If you have a complex condition, you might have heard the phrase “clinical trial” at…

Read the rest of this entry

Promising phase 1/2 results for entrectinib against ROS1+ non-small cell lung cancer

We are hopeful that entrectinib will help us control many cases of ROS1+ lung cancer in both the body and the brain,” says Robert C. Doebele, MD, PhD.

Read the rest of this entry

P53 “master switch” remains top target in gene signaling network controlling cancer suppression

“There are few things that are as relevant across cancer types as p53. Now the question is what is the best approach to harness it,” says senior author Joaquin Espinosa, PhD.

Read the rest of this entry

Today is Mesothelioma Awareness Day!

Today is Mesothelioma Awareness Day, marked across the country by events raising awareness of the…

Read the rest of this entry

Rob Kinas hosts tennis-themed events to raise money for cancer research

“We do not say no,” says Rob Kinas about his philosophy for events raising monies for American Cancer Society. Kinas recently visited the Jennifer Richer lab at CU Cancer Center to see how the ACS funds research by early-career investigators.

Read the rest of this entry

Help Rochford Lab reach fundraising goal for childhood cancer research

September is childhood cancer awareness month. The Rochford lab is organizing a few different events…

Read the rest of this entry

Antonio Jimeno, MD, PhD, earns R01 grants to make new models testing cancer immunotherapies

Antonio Jimeno, MD, PhD, recently renewed a 5-year NIH R01 grant with a new focus on studying how head and neck cancer stem cells trick the immune system, and obtained another R01 grant to develop new animal models of melanoma that allow the study and testing of immunotherapies against cancer.

Read the rest of this entry

Colorado-Zimbabwe collaboration builds capacity to combat cancer in Africa

CU Cancer Center partnership with Zimbabawe sets stage for development of a Regional Center for Research Excellence, called AfriCARE, meant to benefit the entire region of sub-Saharan Africa.

Read the rest of this entry

Blood tumor markers may warn when lung cancer patients are progressing on targeted treatments

University of Colorado Cancer Center study suggests that rather than screening for disease, blood tumor markers could be useful in monitoring therapeutic outcomes in those with already established disease.

Read the rest of this entry